Significance of low level infliximab in the absence of anti-infliximab antibodies.
暂无分享,去创建一个
R. Eliakim | U. Kopylov | I. Dotan | S. Ben-Horin | R. Loebstein | H. Yanai | Y. Ron | Y. Chowers | M. Yavzori | B. Ungar | A. Anafy | O. Picard | E. Fudim